Cited by 187Mental Health Research TopicsSleep and related disordersCancer survivorship and care

Introducing network intervention analysis to investigate sequential, symptom-specific treatment effects: A demonstration in Co-occurring insomnia and depression

Open access
Blanken, Tessa F., Van Der Zweerde, Tanja, Van Straten, Annemieke, Van Someren, Eus J.W., Borsboom, Denny, Lancee, Jaap·2019·Psychotherapy and Psychosomatics

Abstract

Gemcitabine-based salvage therapy is considered an effective treatment for relapsed and refractory Non-Hodgkin's lymphoma (NHL). We analyzed the outcome of 41 consecutive NHL patients treated with gemcitabine-based regimens between January 2007 and October 2015. Twenty-eight males and 13 females (median age 66.4 years) were included. The median follow-up from gemcitabine initiation was 7.3 months. Thirty patients (73%) had B-cell, and eleven (27%) had T-cell, lymphoma. All patients received a median of 2 prior regimens, of which at least 1 was anthracycline based. Twenty-eight patients (78%) received full-dose while 9 (22%) received reduced-dose regimens. The overall response rate was 37%, with 24% (n = 10) complete response, 12% (n = 5) partial response, and 63% (n = 22) progressive disease or stable disease. The median progression-free survival (PFS) was 47 days (range 12-1,318), the median overall survival (OS) was 1.9 years. Twenty patients (49%) died during follow-up. Grade 3-4 hematological toxicity was reported in 21 patients (51%). Relapsed vs. refractory disease, as well as a response to gemcitabine, predicted better PFS and OS. Use of a full-dose regimen predicted a better OS. Compared to previously published data, we observed less favorable outcomes. The administration of gemcitabine-based therapy as a salvage regimen for patients with relapsed or refractory NHL had limited success. Innovative therapies for these patients are an unmet need.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000495045

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Network intervention analysis extends symptom network models to examine treatment-induced changes in symptoms and their association over time.

    “network intervention analysis, an approach proposed by Blanken et al. (2019), extends symptom network models to examine treatment-induced changes in symptoms and their association over time.”

    From Measuring the active elements of cognitive-behavioral therapies (2023) · cites this paper as Blanken et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Blanken, T. F., Van Der Zweerde, T., Van Straten, A., Van Someren, E. J. W., Borsboom, D., & Lancee, J.
Affiliations
  • Netherlands Institute for Neuroscience (NL)
  • University of Amsterdam (NL)
Venue
Psychotherapy and Psychosomatics
Publisher
S. Karger AG
Published
2019
Volume
88
Issue
1
Pages
52-54
ISSN
  • 0033-3190 (ISSN-L)
  • 1423-0348
OpenAlex
W2910954829
Cited by
187
References
10
Citations by year
2026: 23 · 2025: 33 · 2024: 29 · 2023: 18 · 2022: 16 · 2021: 31 · 2020: 20 · 2019: 17
FWCI
24.76
Type
journal article
Language
en
Open access
Locations
  • Psychotherapy and Psychosomatics (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • VU Research Portal (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • UvA-DARE (University of Amsterdam) (submittedVersion, cc-by-nc-nd)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
Funders
  • Vrije Universiteit Amsterdam
  • H2020 European Research Council (671084)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
insomnia, depression, progression-free survival, overall survival, hematologic toxicity
MeSH terms
Adult, Data Interpretation, Statistical, Depressive Disorder, Humans, Sleep Initiation and Maintenance Disorders, Severity of Illness Index, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review